AG00350I

220127-57-1 | Imatinib mesylate

AG00350I

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	220127-57-1
Catalog Number	AG00350I(AGN-PC-0JLOJX)
Chemical Name	Imatinib mesylate
EC Number	606-892-3
IUPAC Name	methanesulfonic acid;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide
InChI	InChI=1S/C29H31N7O.CH4O3S/c1-21-5-10-25(18-27(21)34-29-31-13-11-26(33-29)24-4-3-12-30-19-24)32-28(37)23-8-6-22(7-9-23)20-36-16-14-35(2)15-17-36;1-5(2,3)4/h3-13,18-19H,14-17,20H2,1-2H3,(H,32,37)(H,31,33,34);1H3,(H,2,3,4)
InChI Key	YLMAHDNUQAMNNX-UHFFFAOYSA-N
MDL Number	MFCD04307699
Molecular Formula	C30H35N7O4S
Molecular Weight	589.7084
NSC Number	716051
SMILES	CS(=O)(=O)O.CC1=C(C=C(C=C1)NC(C1=CC=C(C=C1)CN1CCN(CC1)C)=O)NC1=NC=CC(=N1)C=1C=NC=CC1
UNII	8A1O1M485B
Synonyms	alpha-(4-methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-p-tolu-p-toluidide, CGP 57148, CGP-57148, CGP57148, CGP57148B, Gleevec, Glivec, imatinib, imatinib mesylate, imatinib methanesulfonate, Mesylate, Imatinib, Methanesulfonate, Imatinib, ST 1571, ST1571, STI 571, STI-571, STI571, Imatinib mesylate, 220127-57-1, Gleevec, Glivec, Imatinib mesilate, Imatinib Mesylate (STI571), imatinib methanesulfonate, sti-571, Imatinib (mesylate), CGP-57148B, imatinib monomesylate, ST-1571 Mesylate, 4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide monomethanesulfonate, CGP 57148B, UNII-8A1O1M485B, Imatinib, methanesulfonate salt, CHEBI:31690, HSDB 7142, 8A1O1M485B, NSC-716051, AK-44930, STI 571, Imatinib mesylate, 98%, Imatinib mesylate (USAN), Imatinib mesylate [USAN], DSSTox_CID_20502, DSSTox_RID_79501, DSSTox_GSID_40502, N-(4-methyl-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide methanesulfonate, Q-201232, C30H35N7O4S, 4-[(4-methyl-1-piperazinyl)methyl]-n-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-phenyl]benzamide methanesulfonate, 4-[(4-methyl-1-piperazinyl)methyl]-n-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide methanesulfonate, Benzamide, 4-((4-methyl-1-piperazinyl)methyl)-N-(4-methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)phenyl)-, monomethanesulfonate, methanesulfonic acid; 4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide, CAS-220127-57-1, CGP-57148, NCGC00159456-02, Gleevac, Shantinib, ImatinibMesylate, Imatinib-Mesylate, Imatinib mesylate;, methanesulfonic acid; 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide, Gleevec (TN), Imatinib(free base), Glivec (TN), PubChem18211, PubChem19416, Imatinib mesilate (JAN), imatinib mesylate mesylate, AC1L3WY1, SCHEMBL8217, Gleevec (Imatinib mesylate), Imatinib monomethanesulfonate, CHEMBL1642, Benzamide,monomethanesulfonate, MLS001401456, C29H31N7O.CH4SO3, DTXSID9040502, AOB6752, CGP-571, EX-A954, QTI-571, SYN1046, YLMAHDNUQAMNNX-UHFFFAOYSA-N, BCPP000204, GGP-57148B, HMS2052B09, HMS2233D16, HMS3265E01, HMS3265E02, HMS3265F01, HMS3265F02, HMS3372O12, HMS3394B09, HMS3654C07, ACT05102, BCP01255, EBD22648, KS-000002AE, Tox21_111684, ABP000865, AC-525, CGP 53715, CI0026, FC0015, MFCD04307699, NSC716051, RS0020, s1026, AKOS015852497, Tox21_111684_1, AN-5298, BCP9000776, CCG-101175, KS-1236, NC00425, TRA0018756, NCGC00159456-11, 111GE005, BC215795, CPD000469175, HY-50946, LS-27113, SAM001246622, SMR000469175, SY013513, AB0005762, AB1008575, ST2413118, TL8001825, TL8006192, AM20080900, FT-0080060, FT-0601612, I0936, SW197805-4, EC-000.2338, MFCD04307699 (95%), A-2359, D01441, J10205, 45150-EP2270008A1, 45150-EP2277867A2, 45150-EP2280003A2, 45150-EP2289893A1, 45150-EP2292617A1, 45150-EP2298768A1, 45150-EP2305682A1, 45150-EP2308861A1, 45150-EP2308879A1, 45150-EP2311821A1, 127I571, A809313, A815828, I06-0363, J-523068, Imatinib Mesylate,Gleevec,Glivec,CGP-57148B,STI-571, Imatinib Mesylate/Gleevec, Glivec, CGP-57148B, STI-571, 4-(4-Methyl-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin- 3-yl)-pyrimidin-2-ylamino)-phenyl]-benzamidemethanesulfonic acid salt, 4-(4-Methyl-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide methanesulfonic acid salt, 4-[(4-Methyl-1-piperazinyl)-methyl]-N-{4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]-amino]-phenyl}-benzamide monomethanesulphonate, 4-[(4-methylpiperazin-1-yl)methyl]-N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)benzamide methanesulfonate, 4-[(4-Methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl) amino]phenyl]benzamide methanesulfonate, 4-[(4-methylpiperazin-1-yl)methyl]-N-{4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl}benzamide methanesulfonate, Benzamide, 4-((4-methyl-1-piperazinyl)methyl)-N-(4-methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)phenyl)-monomethanesulfonate, Benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-, methanesulfonate (1:1), methanesulfonic acid; 4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[[4-(3-pyridyl)pyrimidin-2-yl]amino]phenyl]benzamide, methanesulfonic acid;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide, N-(4-methyl-3(4-(pyridin-3-yl)pyridin-2-ylamino)phenyl-4-((4-methylpiperazin-1-yl)methyl)benzamide, N-(4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide methanesulfonate, Imatinib, Imatinib Methansulfonate, Imatinib Mesylate/Glivec, STI571, D0Z6KI, cc-159, 220127-57-1 (mesylate), CID123596, ACN-034468, CS-0027, 152459-95-5, Imatinib mesylate, 98% - 250MG 250mg, A10468, Imatinib Mesylate Multi-target kinase inhibitor of abl, c-kit, and PDGFR, ;4-[(4-Methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide methanesulfonate,

Complexity	799
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	2
Defined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Exact Mass	589.247g/mol
Formal Charge	0
Heavy Atom Count	42
Hydrogen Bond Acceptor Count	10
Hydrogen Bond Donor Count	3
Isotope Atom Count	0
Molecular Weight	589.715g/mol
Monoisotopic Mass	589.247g/mol
Rotatable Bond Count	7
Topological Polar Surface Area	149A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class
Hazard statements	H302-H315-H319-H332-H335
Packing Group
Precautionary statements	P261-P280-P305+P351+P338
UN Code

Certificate of Analysis

Lot Number